HOME >> BIOLOGY >> NEWS
Molecular marker predicts success of breast cancer treatment

A new study demonstrates that the ratio of the expression levels of two genes can be used to accurately predict the clinical outcome of tamoxifen treatment for early stage breast cancer. It is the first method to reliably differentiate between patients who experienced disease-free survival and those at risk for tumor recurrence. The findings also provide new insight into the molecular mechanisms that may contribute to tamoxifen resistance.

Tamoxifen is one of the most widely used therapies for breast cancer. It works by blocking the action of estrogen on breast cancer cells. Estrogen directs the growth of normal breast cells, but can also stimulate the abnormal and unregulated cell growth associated with breast cancer. Unfortunately, nearly 40% of breast cancer patients fail to respond to tamoxifen or eventually become resistant to treatment, and there is no reliable way to predict treatment outcome. Dr. Dennis C. Sgroi from the Pathology Department at Massachusetts General Hospital and Dr. Mark G. Erlander from Arcturus Bioscience, Inc. in Mountain View, California examined the gene expression levels in 60 breast cancers from patients who were treated with tamoxifen after their surgery. Measuring gene expression is a way to examine whether or not a gene is functioning. They discovered that the ratio of the expression levels of two genes, HOXB13 and IL17BR, accurately predicted whether tumors reoccurred after treatment with tamoxifen. The researchers also found that when HOXB13 levels were experimentally elevated in cells from normal breast tissue cultured in the laboratory, the cells showed obvious morphological changes and became more invasive in response to growth signals. "This suggests that HOXB13 may directly contribute to tumor invasion and metastasis," explains Dr. Sgroi.

The researchers conclude that the HOXB13:IL17BR expression ratio may provide an effective molecular marker for identifying breast cancer patients who will be less likely to
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
3-Jun-2004


Page: 1 2

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular image of genotoxin reveals how bacteria damage human DNA
10. Molecular mechanism found that may improve ability of stem cells to fight disease
11. Molecular midwives hold clues to the origin of life

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2019)... ... April 23, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... in Egg Harbor Township, New Jersey. The new facility was custom designed to ...
(Date:4/25/2019)... ... April 24, 2019 , ... NDA Partners Chairman Carl Peck, ... years of experience in the development of drug and genomic diagnostic products for therapeutic ... to joining NDA Partners, Dr. Maddala served as Vice President of Biometrics at GRAIL, ...
(Date:4/25/2019)... (PRWEB) , ... April 25, 2019 , ... ... as well as screening tools, has strengthened its commitment to meeting today’s highest ... used in any application where inhibition of its targeted proteases is needed. Current ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive event series ... announces its Boston CEO conference to be held May 28-29, 2019 at Boston’s ... with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/27/2019)... , ... March 26, 2019 , ... A leader in ... cell services to veterinarians across the United States and Canada since 2004. The ... and soft tissue injuries in the dog, cat, and horse. Recently, VetStem ...
(Date:3/27/2019)... ... ... Lachman is sponsoring the event on April 1-4, where they will be located ... on site will be available to discuss strategies and tactics to support Facilities of ... Executives from Lachman participating at this year’s conference include Fran Zipp, President & CEO, ...
(Date:3/23/2019)... ... March 22, 2019 , ... Tosoh Bioscience ... Scattering (MALS) detector , offering a revolutionary approach for the measurement of molecular ... biopolymers. A novel optical design, a unique cell-block assembly, and a new calculation ...
Breaking Biology Technology:
Cached News: